**Question:** Drug used in treatment of malignant hyperthermia is

A. Dantrolene
B. Midazolam
C. Nitroglycerin
D. Insulin

**Core Concept:**
Malignant hyperthermia (MH) is a severe and potentially fatal complication that can occur during general anesthesia or muscle relaxation, particularly when using certain medications such as sugammadex, succinylcholine, or halothane. It is a genetic disorder characterized by excessive release of calcium ions from sarcoplasmic reticulum in skeletal muscle cells, leading to uncontrolled muscle contractions, overheating, acidosis, and organ dysfunction.

**Why the Correct Answer is Right:**
Dantrolene is the appropriate drug for treating MH because it specifically targets the increased calcium release from sarcoplasmic reticulum, thereby preventing further muscle contractions and reducing core body temperature. It works by binding to and sequestering intracellular calcium ions, preventing their release into the cytoplasm and restoring normal muscle function.

**Why Each Wrong Option is Incorrect:**

A. Midazolam (a benzodiazepine) is a sedative and anxiolytic agent used for anesthesia and sedation. While it can be used to manage some aspects of MH, it does not directly address the underlying calcium dysregulation causing muscle contractions.

B. Nitroglycerin (a nitric oxide donor) is primarily used for treating angina and hypertension, not related to MH management. It does not target calcium dysregulation or muscle overactivity.

C. Insulin (an anabolic hormone) is primarily used for diabetes treatment and does not have any direct effect on calcium homeostasis or muscle contractions associated with MH.

**Clinical Pearl:**
Malignant hyperthermia can be managed with a combination of rapid cooling, benzodiazepines, and calcium channel blockers like dantrolene. It is essential to recognize and treat MH promptly to prevent severe complications and potential fatality.